Reinhard J. Ambros - 28 Feb 2024 Form 4/A Insider Report for Aileron Therapeutics, Inc. (RNTX)

Role: Director
Signature: /s/ Brian Windsor, attorney-in-fact for Reinhard J. Ambros
Issuer symbol: RNTX
Transactions as of: 28 Feb 2024
Net transactions value: $0
Form type: 4/A
Filing time: 10 Apr 2024, 16:15:05 UTC
Date Of Original Report: 01 Mar 2024
Previous filing: 17 Jun 2022
Next filing: 22 Aug 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALRN	Stock Option (right to buy)	Award	$0	+2,725		$0.000000	2,725	28 Feb 2024	Common Stock	2,725	$4.72	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on February 28, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) February 28, 2025 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders.

Remarks:

This amendment to Form 4 is being filed solely to correct the exercise price of the granted options previously reported as being $4.80 to $4.72, the adjusted closing price of the Issuer's stock on February 28, 2024.